Linezolid Treatment for Osteomyelitis Due to Vancomycin‐ResistantEnterococcus faecium | Zendy

Michele Till | Zendy; Richard L. Wixson | Zendy; Peter Pertel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Linezolid Treatment for Osteomyelitis Due to Vancomycin‐ResistantEnterococcus faecium

Author(s) -

Michele Till,

Richard L. Wixson,

Peter Pertel

Publication year - 2002

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/340265

Subject(s) - linezolid , enterococcus faecium , medicine , vancomycin , osteomyelitis , enterococcus , vancomycin resistant enterococcus , incidence (geometry) , antibiotics , microbiology and biotechnology , surgery , staphylococcus aureus , bacteria , biology , physics , optics , genetics

The incidence of nosocomial infections caused by vancomycin-resistant enterococci has risen substantially during the past 15 years. We report the use of linezolid for the successful treatment of hip prosthesis infection associated with osteomyelitis due to vancomycin-resistant Enterococcus faecium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research